000 | 01613 a2200469 4500 | ||
---|---|---|---|
005 | 20250513231543.0 | ||
264 | 0 | _c20010201 | |
008 | 200102s 0 0 eng d | ||
022 | _a0077-8923 | ||
024 | 7 |
_a10.1111/j.1749-6632.2000.tb06978.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGomariz, R | |
245 | 0 | 0 |
_aAnti-inflammatory actions of VIP/PACAP. Role in endotoxemia. _h[electronic resource] |
260 |
_bAnnals of the New York Academy of Sciences _c2000 |
||
300 |
_a284-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCytokines _xgenetics |
650 | 0 | 4 |
_aEndotoxemia _xetiology |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aInflammation _xetiology |
650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
650 | 0 | 4 | _aMacrophage Activation |
650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNeuropeptides _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide Synthase _xgenetics |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aPituitary Adenylate Cyclase-Activating Polypeptide |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
700 | 1 | _aLeceta, J | |
700 | 1 | _aMartinez, C | |
700 | 1 | _aAbad, C | |
700 | 1 | _aGanea, D | |
700 | 1 | _aDelgado, M | |
773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 921 _gp. 284-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.2000.tb06978.x _zAvailable from publisher's website |
999 |
_c11132018 _d11132018 |